Multiple Sclerosis Clinical Trial
Official title:
Integrating Caregiver Support Into MS Care
Verified date | May 2019 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
With loss of mobility in multiple sclerosis (MS) comes an increase in amount and types of
caregiver assistance, with a concomitant increase in burden for the caregiver. In fact,
effect on caregiver burden can be seen as a potential indicator of the efficacy of MS
management, suggesting that the caregiver is an appropriate and independent target for MS
therapeutic strategies.
MS patients report difficulty implementing and continuing with home exercise, mobility, and
walking programs. This feasibility study will test integration of a successful behavioral
caregiving intervention into clinical practice to improve functioning of Veterans with
multiple sclerosis (MS) and their Caregivers. Caregivers of Veterans with MS will receive a
behavioral caregiver intervention designed to address caregiver coping and management of
patient concerns, with special focus on patient mobility and walking. A pre-post intervention
design will compare outcomes for Veterans and Caregivers.
For Veterans, the intervention will target Caregiver participation in home-based Veteran
mobility activities. MS Caregivers report high burden, stress, and depression involved in
caring for their loved ones, especially as mobility declines and these outcomes are related
to physical and emotional health status of the patient. For Caregivers, the intervention will
focus on improving Caregiver coping and on managing MS-related problems. Outcomes for both
will be measured at baseline, 3 months, and 6 months.
Study Objectives include:
- Test whether a caregiver intervention can be integrated into an MS clinical setting.
- Determine whether Caregiver outcomes are improved (depression, burden, anxiety, and
number of Veteran MS problems and safety alerts reported).
- Determine whether Veteran outcomes are improved (Expanded Disability Status Scale, timed
up and go test, self-efficacy, and depression).
- Determine which types of Caregivers will benefit most.
- Determine which types of Veterans will benefit most.
- Refine materials for future clinical research, translation and implementation.
Status | Completed |
Enrollment | 25 |
Est. completion date | June 30, 2018 |
Est. primary completion date | April 9, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Veteran being seen in MS clinic at Memphis VA - Veteran ambulatory - Caregiver/care partner who agrees to participate Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
United States | Memphis VA Medical Center, Memphis, TN | Memphis | Tennessee |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development | Memphis VA Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Depression Measured With the Patient Health Questionnaire 9 (PHQ-9) Scale | Caregiver primary outcome. PHQ-9, range 0-27, lower better | baseline, 6 months | |
Primary | Burden Measured With the Zarit Burden Inventory | Caregiver primary outcome. Zarit Burden Inventory, 12 item, 0-48, lower better | baseline, 6 months | |
Primary | Anxiety Measured With the Generalized Anxiety Disorders 7 Scale | Caregiver primary outcome. General Anxiety Disorders Scale - GAD-7, range 0-21, lower better | baseline, 6 months | |
Primary | Number of Patient MS Problems | Caregiver primary outcome - number of possible troubling patient problems and concerns, range 0-27, lower better | baseline, 6 months | |
Primary | Bother With Patient MS Problems | Number of troubling patient problems or concerns that bother the caregiver, range 0-27, lower better | Baseline, 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |